BLRX
BioLineRX
BLRX
BLRX
12 hedge funds and large institutions have $5.12M invested in BioLineRX in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$2.92M |
| 2 |
CS
2
Credit Suisse
Zurich,
Switzerland
|
$0 |
| 3 |
3
Citigroup
New York
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $2.92M | 1,335,000 | -254,500 | -16% |
|
|
SM
2
Senvest Management
New York
| $1.51M | 691,154 | +66,481 | +11% |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $446K | 204,580 | +80,578 | +65% |
|
4
Renaissance Technologies
New York
| $135K | 61,600 | +31,745 | +106% |
|
5
Bank of New York Mellon
New York
| $39K | 17,800 | – | – |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $27K | 12,000 | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| $24K | 10,701 | +10,701 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4K | 1,723 | +1,723 | New |
|
9
Wells Fargo
San Francisco,
California
| $2K | 1,000 | – | – |
|
|
10
Citigroup
New York
| $1K | 483 | -90 | -16% |
|
|
CS
11
Credit Suisse
Zurich,
Switzerland
| – | – | -15,432 | Closed |
|
|
SSG
12
Summit Securities Group
New York
| – | – | -11 | Closed |
|
13
Ameriprise
Minneapolis,
Minnesota
| $0 | 10 | – | – |
|
14
Creative Planning
Overland Park,
Kansas
| $0 | 140 | – | – |
|